JP2022515838A5 - - Google Patents

Info

Publication number
JP2022515838A5
JP2022515838A5 JP2021537818A JP2021537818A JP2022515838A5 JP 2022515838 A5 JP2022515838 A5 JP 2022515838A5 JP 2021537818 A JP2021537818 A JP 2021537818A JP 2021537818 A JP2021537818 A JP 2021537818A JP 2022515838 A5 JP2022515838 A5 JP 2022515838A5
Authority
JP
Japan
Prior art keywords
nucleic acid
alox15
acid molecule
seq
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021537818A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022515838A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/068328 external-priority patent/WO2020139830A2/en
Publication of JP2022515838A publication Critical patent/JP2022515838A/ja
Publication of JP2022515838A5 publication Critical patent/JP2022515838A5/ja
Pending legal-status Critical Current

Links

JP2021537818A 2018-12-28 2019-12-23 アラキドン酸15-リポキシゲナーゼ(alox15)阻害剤による呼吸器障害の治療 Pending JP2022515838A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862785899P 2018-12-28 2018-12-28
US62/785,899 2018-12-28
PCT/US2019/068328 WO2020139830A2 (en) 2018-12-28 2019-12-23 Treatment of respiratory disorders with arachidonate15-lipoxygenase (alox15) inhibitors

Publications (2)

Publication Number Publication Date
JP2022515838A JP2022515838A (ja) 2022-02-22
JP2022515838A5 true JP2022515838A5 (cg-RX-API-DMAC7.html) 2022-12-13

Family

ID=69326713

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021537818A Pending JP2022515838A (ja) 2018-12-28 2019-12-23 アラキドン酸15-リポキシゲナーゼ(alox15)阻害剤による呼吸器障害の治療

Country Status (11)

Country Link
US (2) US12472241B2 (cg-RX-API-DMAC7.html)
EP (1) EP3902567A2 (cg-RX-API-DMAC7.html)
JP (1) JP2022515838A (cg-RX-API-DMAC7.html)
KR (1) KR20210110623A (cg-RX-API-DMAC7.html)
CN (1) CN113423435A (cg-RX-API-DMAC7.html)
AU (1) AU2019417718B2 (cg-RX-API-DMAC7.html)
CA (1) CA3124670A1 (cg-RX-API-DMAC7.html)
IL (1) IL284046A (cg-RX-API-DMAC7.html)
MX (1) MX2021007938A (cg-RX-API-DMAC7.html)
SG (1) SG11202106517WA (cg-RX-API-DMAC7.html)
WO (1) WO2020139830A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3911632A1 (en) 2019-01-15 2021-11-24 Empirico Inc. Prodrugs of alox-15 inhibitors and methods of using the same

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932425A (en) 1997-02-18 1999-08-03 Signal Pharmaceuticals, Inc. Compositions and methods for modulating cellular NF-κB activation
FR2762841B1 (fr) 1997-04-30 1999-07-02 Jouveinal Inst Rech Diazepino-indolones inhibitrices de phosphodiesterases iv
HUP0001054A3 (en) 1997-08-06 2001-01-29 Daiichi Asubio Pharma Co Ltd 1-aryl-1,8-naphthyridin-4-one derivative as type iv phosphodiesterase inhibitor
IT1296984B1 (it) 1997-12-19 1999-08-03 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4
DK1076657T3 (da) 1998-04-28 2004-11-08 Elbion Ag Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling
AU757198B2 (en) 1998-06-10 2003-02-06 Altana Pharma Ag Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
IT1302677B1 (it) 1998-10-15 2000-09-29 Zambon Spa Derivati benzazinici inibitori della fosfodiesterasi 4
IT1303272B1 (it) 1998-10-29 2000-11-06 Zambon Spa Derivati triciclici inibitori della fosfodiesterasi 4
US6686502B1 (en) 1999-03-26 2004-02-03 Ucb S.A. Compounds and methods for treatment of asthma, allergy and inflammatory disorders
US6740666B2 (en) 2000-12-20 2004-05-25 Merck & Co., Inc. Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
ATE303384T1 (de) 2001-05-24 2005-09-15 Merck Frosst Canada Inc 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
JO2311B1 (en) 2001-08-29 2005-09-12 ميرك فروست كندا ليمتد Alkyl inhibitors Ariel phosphodiesterase-4
AR037517A1 (es) 2001-11-05 2004-11-17 Novartis Ag Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
IS7839A (is) 2002-11-22 2004-05-23 Merck Frosst Canada Ltd. 4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar
MY141255A (en) 2003-12-11 2010-03-31 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
EP2747762B1 (en) 2011-08-23 2015-07-01 Cornerstone Therapeutics Inc. Use of zileuton for the treatment of nasal polyps in cystic fibrosis patients
US10132809B2 (en) 2012-10-10 2018-11-20 Rhote Island Hospital Differential expression of protein markers for the diagnosis and treatment of eosinophilic esophagitis
RS59354B1 (sr) 2013-06-21 2019-10-31 Sanofi Biotechnology Postupci lečenja nosne polipoze davanjem il-4r antagonista
EP3735248A4 (en) 2018-02-09 2021-11-17 Empirico Inc. PROCESS FOR INHIBITED OR ELIMINATING EOSINOPHILIC DISEASES OF THE RESPIRATORY TRACT AND ASSOCIATED CONDITIONS

Similar Documents

Publication Publication Date Title
JP2022523301A5 (cg-RX-API-DMAC7.html)
JP2006500949A5 (cg-RX-API-DMAC7.html)
JP2008520242A5 (cg-RX-API-DMAC7.html)
CN1932041B (zh) 对于赤鹿、梅花鹿、马鹿以及驯鹿的基因特异的引物以及利用该引物识别鹿茸品种的方法
KR102029775B1 (ko) 비근침윤성 방광암 진단용 바이오마커 및 이의 용도
WO2008109773A2 (en) Chronic obstructive pulmonary disease susceptibility and related compositions and methods
JP6619332B2 (ja) ヒトezh2遺伝子中の変異を検出するための方法及び組成物
JP2023531935A5 (cg-RX-API-DMAC7.html)
JP2016533708A5 (cg-RX-API-DMAC7.html)
JP2008512984A5 (cg-RX-API-DMAC7.html)
JP2005537007A5 (cg-RX-API-DMAC7.html)
JP2024521754A5 (cg-RX-API-DMAC7.html)
JP2008545390A (ja) 遺伝的多型を用いた肺癌を発達させるリスクの評価方法
JP2022525545A5 (cg-RX-API-DMAC7.html)
JP2022525456A5 (cg-RX-API-DMAC7.html)
JP2022525546A5 (cg-RX-API-DMAC7.html)
CN118581217A (zh) 一种用于mlh1基因启动子区域的甲基化核酸序列及试剂盒
KR101683086B1 (ko) 유전자의 발현량 및 메틸화 프로필을 활용한 돼지의 산자수 예측방법
CN108676852B (zh) 在外周血游离dna中检测p53基因表观遗传学修饰差异的引物对组及试剂盒
WO2017118230A1 (zh) 用于诊断骨肉瘤的miRNA标志物
RU2023131494A (ru) Лечение цереброваскулярного заболевания с помощью агентов - белков-гомологов 3 нейрогенного локуса notch (notch3)
RU2021122161A (ru) Лечение респираторных нарушений с помощью ингибиторов арахидонат 15-липоксигеназы (alox15)
CN116377053B (zh) 冠状动脉扩张症的诊断生物标志物及其应用
RU2021121850A (ru) Лечение офтальмологических патологических состояний ингибиторами ангиопоэтин-подобного белка 7 (angptl7)
JP2024536001A5 (cg-RX-API-DMAC7.html)